Description
| Specialty | COARAVEN |
|---|---|
| Dosage | 300 mg, 12.5 mg |
| Form | Film-coated tablet |
| Presentation | Box of 90 |
| Primary packaging | Blister |
| Specification | Opaque white PVC/PVDC/Alu |
| INN | HYDROCHLOROTHIAZIDE, IRBESARTAN |
| VEIC Classification | Essential |
| Therapeutic class | CARDIOVASCULAR SYSTEM |
| Subclass | Agents acting on the renin-angiotensin system |
| Laboratory | PHILADELPHIA PHARMA |
| Schedule | A |
| Shelf life | 24 months |
| Generic/Originator | Generic |
| Marketing Authorization (MA) | 9353049 |
| MA date | 2014-08-12 |
| Range | Cardio-Metabolic |
Reviews
There are no reviews yet.